54,640 Varex Imaging $VREX Shares Sold by Cooke & Bieler LP

Cooke & Bieler LP cut its stake in Varex Imaging (NASDAQ:VREX) by 5.5% in the third quarter, HoldingsChannel reports. The fund owned 944,511 shares of the company’s stock after selling 54,640 shares during the period. Cooke & Bieler LP’s holdings in Varex Imaging were worth $17,426,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Fortitude Family Office LLC lifted its position in shares of Varex Imaging by 1,643.6% during the 3rd quarter. Fortitude Family Office LLC now owns 2,441 shares of the company’s stock valued at $45,000 after buying an additional 2,301 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Varex Imaging by 65.4% in the third quarter. GAMMA Investing LLC now owns 1,657 shares of the company’s stock valued at $31,000 after purchasing an additional 655 shares in the last quarter. Farther Finance Advisors LLC boosted its position in shares of Varex Imaging by 177.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 3,559 shares of the company’s stock valued at $66,000 after acquiring an additional 2,274 shares during the last quarter. Engineers Gate Manager LP purchased a new stake in shares of Varex Imaging in the 2nd quarter valued at approximately $542,000. Finally, Integrated Wealth Concepts LLC purchased a new position in Varex Imaging in the second quarter worth approximately $32,000.

Varex Imaging Trading Up 0.1%

NASDAQ:VREX opened at $18.42 on Thursday. The company has a quick ratio of 1.53, a current ratio of 3.38 and a debt-to-equity ratio of 0.64. The company has a market capitalization of $775.48 million, a PE ratio of 35.42 and a beta of 0.97. The stock has a fifty day simple moving average of $18.47 and a 200-day simple moving average of $13.69. Varex Imaging has a 52-week low of $9.09 and a 52-week high of $18.63.

Varex Imaging (NASDAQ:VREX) last posted its earnings results on Monday, August 10th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.10. The firm had revenue of $210.50 million for the quarter, compared to analyst estimates of $215.50 million. Varex Imaging had a return on equity of 9.19% and a net margin of 2.55%. On average, equities research analysts expect that Varex Imaging will post 1.04 earnings per share for the current fiscal year.

Insider Activity at Varex Imaging

In other Varex Imaging news, CFO Shubham Maheshwari sold 130,000 shares of the stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $18.46, for a total transaction of $2,399,800.00. Following the transaction, the chief financial officer owned 139,972 shares of the company’s stock, valued at $2,583,883.12. This trade represents a 48.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jay Kunkel sold 8,121 shares of Varex Imaging stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $18.48, for a total value of $150,076.08. Following the completion of the transaction, the director directly owned 15,329 shares in the company, valued at $283,279.92. This represents a 34.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 4.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a report on Saturday, July 4th. Zacks Research cut Varex Imaging from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 27th. CJS Securities cut shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 17th. Sidoti restated a “neutral” rating and set a $19.00 target price on shares of Varex Imaging in a research note on Monday, August 10th. Finally, B. Riley Financial lowered Varex Imaging from a “buy” rating to a “hold” rating in a report on Monday, August 10th. Seven analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, Varex Imaging currently has a consensus rating of “Hold” and an average target price of $16.88.

Varex Imaging Company Profile

Varex Imaging Corporation develops and manufactures X-ray imaging components used in medical, industrial, and security applications. Its products are incorporated into systems that support diagnostic imaging, radiation therapy, baggage inspection, cargo screening, and other imaging processes.

The company’s product portfolio includes X-ray tubes, digital detectors, image-processing software, high-voltage connectors, and other components for X-ray imaging systems. Varex also provides software and services designed to support image quality, system performance, and equipment integration.

Varex serves equipment manufacturers and other customers worldwide, with applications spanning healthcare, industrial inspection, and security screening.